FDA Drug Recalls

Recalls / Class II

Class IID-0570-2020

Product

fentaNYL 1500 mcg/30 mL (50 mcg/mL) 30 mL PCA Vial Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1180-79

Affected lot / code info
Lots: 10030060 Exp. 11/21/2019, 10030574 Exp. 11/28/2019, 10031353 Exp. 12/12/2019, 10031677 Exp. 12/20/2019, 10031622 Exp. 12/19/2019, 10031419 Exp. 12/15/2019, 10031769 Exp. 12/26/2019, 10031826 Exp. 12/23/2019, 10032287 Exp. 12/30/2019

Why it was recalled

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Recalling firm

Firm
QuVa Pharma, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1075 W Park One Dr Ste 100, Sugar Land, Texas 77478-2576

Distribution

Distribution pattern
Nationwide.

Timeline

Recall initiated
2019-11-12
FDA classified
2019-12-03
Posted by FDA
2019-12-11
Terminated
2020-06-05
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0570-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.